Begin main content

The Path Forward for Integrating Key Functions of the Cancer Drug Implementation Advisory Committee (CDIAC) Into CADTH’s pan-Canadian Oncology Drug Review (pCODR) Process

June 12, 2019
We are pleased to announce that process and operational changes have been made to transition Cancer Drug Implementation Advisory Committee (CDIAC) functions to CADTH effective July 1, 2019.  These changes will further enhance the transparency of the CADTH pan-Canadian Oncology Drug Review (pCODR) review process and better support public pay...

Pharmaceutical Reviews Update 8

May 23, 2019
See Pharmaceutical Reviews Update – Issue 8 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include: details around when patient groups may be re-engaged in the CADTH Common Drug Review (CDR) process following an initial call for patient input an announcement on a...

New at CADTH - May 2019

May 7, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Pharmaceutical Reviews Update 7

April 17, 2019
See Pharmaceutical Reviews Update – Issue 7 for important news and information regarding CADTH’s drug review programs. This issue includes changes to the CADTH Common Drug Review procedure to include an additional embargo period for CDEC recommendations that have been substantially revised following a request for reconsiderat...